Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Candel Therapeutics, Inc. | 136,500 | reported | 26 Jan 2026 | tx 23+656,258−135,222 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jan 2026 | GRANT_AWARD | Candel Therapeutics, Inc. | 136,500 | 0.00 USD | deriv |
| 28 Jul 2025 | EXERCISE | Candel Therapeutics, Inc. | 937 | 1.29 USD | |
| 28 Jul 2025 | SALE | Candel Therapeutics, Inc. | 937 | 6.98 USD | |
| 28 Jul 2025 | EXERCISE | Candel Therapeutics, Inc. | 937 | 0.00 USD | deriv |
| 30 Jun 2025 | EXERCISE | Candel Therapeutics, Inc. | 781 | 1.29 USD | |
| 30 Jun 2025 | SALE | Candel Therapeutics, Inc. | 781 | 5.04 USD | |
| 30 Jun 2025 | EXERCISE | Candel Therapeutics, Inc. | 781 | 0.00 USD | deriv |
| 18 Mar 2025 | EXERCISE | Candel Therapeutics, Inc. | 4,584 | 3.75 USD | |
| 18 Mar 2025 | EXERCISE | Candel Therapeutics, Inc. | 13,905 | 1.29 USD | |
| 18 Mar 2025 | SALE | Candel Therapeutics, Inc. | 45,316 | 8.76 USD | |
| 18 Mar 2025 | EXERCISE | Candel Therapeutics, Inc. | 4,584 | 0.00 USD | deriv |
| 18 Mar 2025 | EXERCISE | Candel Therapeutics, Inc. | 13,905 | 0.00 USD | deriv |
| 12 Feb 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 107,250 | 0.00 USD | deriv |
| 15 Jan 2025 | SALE | Candel Therapeutics, Inc. | 10,428 | 7.23 USD | |
| 08 Jan 2025 | SALE | Candel Therapeutics, Inc. | 10,799 | 8.22 USD | |
| 29 Nov 2024 | SALE | Candel Therapeutics, Inc. | 13,935 | 4.56 USD | |
| 17 Jul 2024 | SALE | Candel Therapeutics, Inc. | 10,875 | 6.47 USD | |
| 11 Jul 2024 | SALE | Candel Therapeutics, Inc. | 9,769 | 5.97 USD | |
| 28 Nov 2023 | TAX_WITHHOLDING | Candel Therapeutics, Inc. | 12,175 | 0.90 USD | |
| 26 Nov 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 88,822 | 0.00 USD | |
| 28 Apr 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 28 Nov 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 58,479 | 0.00 USD | |
| 12 Sept 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |